Explore
Validate
Learn14335-1-AP
antibody from Proteintech Group
Targeting: CADM1
BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14335-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14335-1-AP, RRID:AB_2243801
- Product name
- CADM1 antibody
- Antibody type
- Polyclonal
- Description
- CADM1 antibody (Cat. #14335-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Mucous cell histopathology and label-free quantitative proteomic analysis of skin mucus in fat greenling (Hexagrammos otakii) infected with Vibrio harveyi.
Nanointegrative Glycoengineering-Activated Necroptosis of Triple Negative Breast Cancer Stem Cells Enables Self-Amplifiable Immunotherapy for Systemic Tumor Rejection.
CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells.
miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma.
miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1.
Necl-4/SynCAM-4 is expressed in myelinating oligodendrocytes but not required for axonal myelination.
Wei X, Shi Y, Wang S, Liu H, Zhang Z, Yu L, Hua W, Cui D, Chen Y, Li X, Wang W
Fish & shellfish immunology 2024 Mar;146:109398
Fish & shellfish immunology 2024 Mar;146:109398
Nanointegrative Glycoengineering-Activated Necroptosis of Triple Negative Breast Cancer Stem Cells Enables Self-Amplifiable Immunotherapy for Systemic Tumor Rejection.
Zhao Y, Li Y, He J, Li M, Yao X, Yang H, Luo Z, Luo P, Su M
Advanced healthcare materials 2024 Apr;13(9):e2303337
Advanced healthcare materials 2024 Apr;13(9):e2303337
CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells.
Xie B, Zhao L, Zhang Z, Zhou C, Tian Y, Kang Y, Chen J, Wei H, Li L
BMC cancer 2023 Oct 9;23(1):955
BMC cancer 2023 Oct 9;23(1):955
miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma.
Li Y, Liu J, Hu W, Zhang Y, Sang J, Li H, Ma T, Bo Y, Bai T, Guo H, Lu Y, Xue X, Niu M, Ge S, Wen S, Wang B, Gao W, Wu Y
OncoTargets and therapy 2019;12:10441-10453
OncoTargets and therapy 2019;12:10441-10453
miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1.
Cai H, Miao M, Wang Z
Oncology letters 2018 Aug;16(2):2620-2628
Oncology letters 2018 Aug;16(2):2620-2628
Necl-4/SynCAM-4 is expressed in myelinating oligodendrocytes but not required for axonal myelination.
Zhu Y, Li H, Li K, Zhao X, An T, Hu X, Park J, Huang H, Bin Y, Qiang B, Yuan J, Peng X, Qiu M
PloS one 2013;8(5):e64264
PloS one 2013;8(5):e64264
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CADM1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CADM1. This antibody recognizes human,mouse,rat antigen. The CADM1 antibody has been validated for the following applications: ELISA, WB analysis.
